Commercialization Process

CCI's Commercialization Process ensures that each promising technology receives the critical mass required to proceed to market as effectively and efficiently as possible.

Our goal is to have a process that is educational, engaging, and enjoyable for inventors and ultimately beneficial for patients everywhere.



Idea Submission

Complete an Invention Disclosure Form (IDF), which can be found on our website. Submit to

Idea Submission

Complete an Invention Disclosure Form (IDF), which can be found on our website, and submitted to disclosure@ccf.org.

Work with the Innovation Manager for your Institute to prepare your invention for presentation at the appropriate Peer Review Committee (PRC).

Need Assessment

The invention is presented to a clinical or administrative-specific PRC to be assessed and scored for clinical/technical efficacy. Based on the aggregate score and feedback from clinical and technical experts, a recommendation will be made to evaluate the invention for commercial viability or to close the case.

Viability Assessment

Inventions believed to have clinical and technical merit are transitioned into one of the following Cleveland Clinic Innovations Incubators for consideration: Medical Devices; Therapeutics and Diagnostics; Health Information Technology; or Delivery Solutions.

A business case for the invention is prepared, and the commercial viability and path forward are determined by the CCI Steering Committee, an internal leadership group.


A development plan for the invention is prepared and executed.

CCI reaches out to the market to garner interest and gather relevant feedback. The commercialization strategy is refined and inventions are marketed.


Negotiations are initiated with interested corporate partners or investors.

CCI works to deliver the best terms for a License or NewCo.


Licenses are executed and NewCos are formed. Commercialization activities are now the responsibility of the licensee and/or NewCo.

Licenses are closely monitored by CCI to ensure commercialization activities by the Licensee are on track and NewCos are operated by CCI until appropriately staffed. NewCos are governed by CCI via participation on a Board of Directors until goals of improving patient care are realized.


Cases may be closed at any point during the Need Assessment, Viability Assessment, Enhancement, or Negotiation stages. Cases are closed when clinical need or efficacy is not established by the Peer Review Committee, the invention is deemed not commercially viable, not protectable, or unfeasible by the CCI Incubator, or deemed not marketable by various corporate partners or investors.

Cases may also be temporarily closed if they are not sufficiently fleshed out or ready for market entry. In these instances, inventions will be returned to the inventor for further refinement.

Innovations Spotlight

Alliance Partners

The Alliance network strives to realize new opportunities for innovation by gaining a 360-degree perspective on healthcare and its future.

Read More

Innovations Team

Cleveland Clinic Innovations (CCI) is the commercialization arm of Cleveland Clinic

Read More